Radio and PodcastRadio and PodcastLive Radio & Podcasts
Asco '26 artwork
Science & Medicine

Asco '26

OncoPharm by OncoPharmPod

Jun 11, 202600:25:38Science & Medicine

ASCO 2026 is a wrap, and we needed an extra week to digest it all! Here the review list: 1. RASolute 302 - daraxonrasib and its standing ovation 2. MajesTEC-9 - 2L teclistamab in multiple myeloma in patient population 10...

About This Episode

Asco '26 is an episode from OncoPharm by OncoPharmPod. ASCO 2026 is a wrap, and we needed an extra week to digest it all! Here the review list: 1. RASolute 302 - daraxonrasib and its standing ovation 2. MajesTEC-9 - 2L teclistamab in multip...

Podcast

This episode belongs to OncoPharm.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jun 11, 2026, 00:25:38 long, audio available.

Related Episodes

Continue listening to more episodes from OncoPharm.

Pivekimab sunirine

May 28, 2026 - 00:13:49

Pivekimab sunirine, a novel CD-123 antibody drug conjugate is approved for Blastic Plasmacytoid Dendritic...

IMHOTEP, PJP, and more

May 14, 2026 - 00:09:59

This week's pod has lots of updates! IMHOTEP: Pre-operative doses of pembrolizumab lead to significant pC...

Vepdegestrant

May 7, 2026 - 00:11:35

The latest FDA drug approval is vepdegestrant, a heterobifunctional protein degrader, for ESR1 mutated br...

Targets Trop 2

Apr 30, 2026 - 00:12:41

This is our 1st in a series of podcasts/videos to role out once or twice a year on therapeutic targets in...

Promising Pancreatic Cancer Data

Apr 23, 2026 - 00:13:56

This week we highlight some promising clinical research in the pancreatic cancer space. Daraxonrasib has...

ICI-Induced T1DM

Apr 16, 2026 - 00:13:24

Bibliography: 1.. 2019 Systematic Review of Published Cases: 2. Mass General Data & Publication: 3. Japan...